A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/4015 (2006.01) A61P 25/28 (2006.01) C07D 207/27 (2006.01)
Patent
CA 2457982
N-(2,6-dimethylphenyl)-2-(2-oxo-1-pyrrolidinyl)acetamide and salts thereof are used for the preparation of medicaments, particularly of pharmaceutical compositions containing it as in an active ingredient, for the treatment of neurodegeneration, in particular in post-stroke human patients. The early administration of nefiracetam or its salt in said pharmaceutical compositions after a stroke allows an improvement of the Activities of Daily Living and the recovery, or at least in improvement in the recovery of, post-stroke patients.
On utilise N-(2,6-diméthylphényl)-2-(2-oxo-1-pyrrolidinyl)acétamide, ainsi que ses sels, dans la préparation de médicaments, en particulier de compositions pharmaceutiques dont il constitue le principe actif, pour le traitement de la neurodégénérescence, notamment chez les patients humains ayant subi un accident vasculaire cérébral. L'administration rapide, après l'accident vasculaire cérébral, de la nefiracétame ou de son sel dans lesdites compositions pharmaceutiques favorise l'amélioration des activités quotidiennes et la récupération, au moins partielle, des patients.
Otomo Eiichi
Takasu Yoshiyuki
Daiichi Pharmaceutical Co. Ltd.
Hamilton Pharmaceuticals Inc.
Riches Mckenzie & Herbert Llp
LandOfFree
Use of nefiracetam for treating neurodegeneration does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of nefiracetam for treating neurodegeneration, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of nefiracetam for treating neurodegeneration will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1896601